FAQ

FAQ

Where is Optinose’s Corporate headquarters?

777 Township Line Road
Suite 300
Yardley, PA 19067

Where is Optinose incorporated?

Optinose is incorporated in the state of Delaware.

When is Optinose’s fiscal year-end?

Optinose’s fiscal year end is December 31st.

Who is Optinose’s independent registered public accounting firm?

Optinose’s independent registered public accounting firm is Ernst & Young, LLP.

Who is Optinose’s corporate counsel?

Optinose’s corporate counsel is Hogan Lovells US LLP

On which exchange is Optinose listed and what is the ticker symbol?

Optinose is traded on the NASDAQ stock exchange under the symbol OPTN.

When did Optinose go public?

Optinose went public on October 13, 2017.

How can I purchase shares of Optinose?

Shares of Optinose may be purchased through a stockbroker of your choice.

Does Optinose have a direct stock purchase plan?

No, Optinose does not offer a direct stock purchase plan.

Who is Optinose’s transfer agent and how do I contact them?

Optinose’s transfer agent is Broadridge Corporate Issuer Solutions, Inc. (Broadridge). You can find more information about how to contact Broadridge at: http://www.broadridge.com.

How can I replace my lost stock certificates?

Please contact Optinose’s transfer agent, Broadridge Corporate Issuer Solutions, Inc., at 1717 Arch Street, Suite 1300, Philadelphia, Pennsylvania 19103 or shareholder@broadridge.com. Broadridge can look up your records and make any necessary adjustments. There is generally a fee involved for replacing lost certificates.

How do I report a change of mailing address?

You must send both your old and new addresses to Optinose’s transfer agent, Broadridge Corporate Issuer Solutions, Inc., by U.S. mail. Each stockholder in question must sign the request for an address change.

Where can I view documents that Optinose has filed with the Securities & Exchange Commission (SEC)?

Optinose’s SEC filings can be accessed under "SEC Filings" in the "Investors" section of our corporate website or www.sec.gov.

Where can I find recent Optinose press releases?

You can view Optinose’s recent press releases by visiting the “News and Media’ section of the website. If you would like to receive press release email alerts, click on the ‘Sign up for email alerts’ link under the ‘Toolkit’ section of the right hand navigation.

Who can I contact if I am a member of the media?

For media inquiries, please send an e-mail to investors@optinose.com

How do I contact Investor Relations with a question or request?

For investor related questions, please send an email to investors@optinose.com

Where can I find the IRS Form 8937 related to the reverse split completed in December 2024?

IRS Form 8937 related to the reverse split completed by Optinose in December 2024 can be found here.

Investors


Toolkit